Biora Therapeutics Inc expected to post a loss of 59 cents a share - Earnings Preview

Biora Therapeutics

22/03/2024 20:37

* Biora Therapeutics Inc  BIOR.OQ   BIOR.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 26
for the period ending December 31 2023
    * The San Diego California-based  company is expected to
report a
96.4% decrease in revenue to $5 hundred from $14 thousand a year
ago, according to the mean estimate from 2 analysts, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Biora Therapeutics Inc
is for
a loss of 59 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $27.80​, above​ its last closing price
of $1.19. ​​​

This summary was machine generated March 22 at 20:37 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)